Insider · CIK 0001316163

Colowick Alan

Reports to the SEC for 10 companies · WALTHAM, MA

sec.gov

Transactions

Companies

Filings

CIK

0001316163

Forms 4 and 5

Insider transactions

40 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-02	ALMSALUMIS INC.P Purchase	Director	PPurchase	+2,300 sh	$7.49	+$17.2K	18,404
2025-04-01	ALMSALUMIS INC.P Purchase	Director	PPurchase	+16.1K sh	$6.97	+$112K	16,104
2023-05-17	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2023-04-01	Harpoon Therapeutics, Inc.A Award	Director	AAward	+16.5K sh	—	—	16,456
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2022-06-22	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+28.6K sh	$1.40	+$40K	28,571
2022-05-17	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15K sh	—	—	15,035
2022-05-17	PSNLPersonalis, Inc.A Award	Director	AAward	+10.8K sh	—	—	13,506
2021-05-14	PSNLPersonalis, Inc.A Award	Director	AAward	+2,736 sh	—	—	2,736
2021-05-14	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,229 sh	—	—	4,229
2021-05-04	Harpoon Therapeutics, Inc.Director Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,167
2021-03-24	Harpoon Therapeutics, Inc.Director Stock Option (right to buy)A Award	Director	AAward	+20.3K sh	—	—	20,335
2020-09-28	Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.2K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−47.7K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20.5K sh	—	—	0
2020-09-28	Principia Biopharma Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10.2K sh	—	—	0
2020-07-01	Principia Biopharma Inc.S Sale	Director	SSale	−7,500 sh	$60.00	−$450K	0
2020-07-01	Principia Biopharma Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	$4.54	+$34.1K	7,500
2020-07-01	Principia Biopharma Inc.Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	47,724
2020-06-04	Principia Biopharma Inc.Director Stock Option (right to buy)A Award	Director	AAward	+10.2K sh	—	—	10,240
2020-05-15	PSNLPersonalis, Inc. · Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	14,000
2020-05-05	Principia Biopharma Inc.Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−6,660 sh	—	—	55,224
2020-05-05	Principia Biopharma Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,660 sh	$4.54	+$30.2K	6,660
2020-05-05	Principia Biopharma Inc.S Sale	Director	SSale	−6,660 sh	$60.00	−$400K	0
2020-05-01	Principia Biopharma Inc.Director Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−840 sh	—	—	61,884
2020-05-01	Principia Biopharma Inc.S Sale	Director	SSale	−840 sh	$60.07	−$50.5K	0
2020-05-01	Principia Biopharma Inc.M Exercise/Conversion	Director	MExercise/Conversion	+840 sh	$4.54	+$3,815.28	840
2019-06-11	Principia Biopharma Inc.Director Stock Option (right to buy)A Award	Director	AAward	+10.2K sh	—	—	10,240
2018-09-13	Principia Biopharma Inc.Director Stock Option (right to buy)A Award	Director	AAward	+20.5K sh	—	—	20,475
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−32.1K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17K sh	—	—	0
2017-11-07	Dimension Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−44.5K sh	—	—	0
2017-06-14	Achaogen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2017-05-25	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+17K sh	—	—	17,000
2016-06-15	Achaogen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-05-19	Dimension Therapeutics, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+32.1K sh	—	—	32,069
2015-03-11	Achaogen, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2008-01-02	GERNGERON CORPI Discretionary Transaction	President, Oncology	IDiscretionary Transaction	+2,705 sh	$5.73	+$15.5K	3,028
2006-09-27	Molecular Templates, Inc.Stock Option (Right to Buy)A Award	Chief Medical Officer	AAward	+150K sh	—	—	150,000
2006-09-26	Molecular Templates, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Medical Officer	DDisposition to Issuer	−150K sh	—	—	0

Recent filings

Accepted (ET)
Apr 34
Colowick Alan0001415889-25-010050
SEC(opens sec.gov)
May 194
Colowick Alan0001209191-23-031231
SEC(opens sec.gov)
Apr 44
Colowick Alan0001209191-23-022796
SEC(opens sec.gov)
Jun 244
Colowick Alan0001209191-22-039324
SEC(opens sec.gov)
May 194
Colowick Alan0001209191-22-030756
SEC(opens sec.gov)
May 184
Colowick Alan0001209191-21-033489
SEC(opens sec.gov)
May 74
Colowick Alan0001209191-21-031111
SEC(opens sec.gov)
Mar 264
Colowick Alan0001209191-21-023255
SEC(opens sec.gov)
Sep 284
Colowick Alan0001209191-20-052228
SEC(opens sec.gov)
Jul 24
Colowick Alan0001209191-20-040793
SEC(opens sec.gov)
Jun 84
Colowick Alan0001209191-20-035137
SEC(opens sec.gov)

Companies

Address

C/O AYURMAYA CAPITAL MANAGEMENT LP 1000 WINTER STREET, SUITE 4500

WALTHAM, MA, 02451